ONCAlert | 2018 ASCO Annual Meeting

Agents Targeted Against PSMA for Prostate Cancer

Scott T. Tagawa, MD, MS
Published Online: 9:29 PM, Mon March 16, 2015


Scott T. Tagawa, MD, MS, associate professor, Clinical Medicine and Urology, Weill Cornell Medical College, discusses PSMA-targeting agents for the treatment of prostate cancer.

Clinical Pearls

  • As resistance to AR-targeted therapy develops, PSMA expression will increase in many patients. An agent targeted against PSMA could be added in at this time.
  • PSMA-targeted therapy could also potentially be used in combination with AR-targeted therapy.
  • Both AR- and PSMA-targeted therapies are being investigated in clinical trials and are already making an impact.


Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.